Literature DB >> 24865429

Splicing regulator SLU7 is essential for maintaining liver homeostasis.

María Elizalde, Raquel Urtasun, María Azkona, María U Latasa, Saioa Goñi, Oihane García-Irigoyen, Iker Uriarte, Victor Segura, María Collantes, Mariana Di Scala, Amaia Lujambio, Jesús Prieto, Matías A Ávila, Carmen Berasain.   

Abstract

A precise equilibrium between cellular differentiation and proliferation is fundamental for tissue homeostasis. Maintaining this balance is particularly important for the liver, a highly differentiated organ with systemic metabolic functions that is endowed with unparalleled regenerative potential. Carcinogenesis in the liver develops as the result of hepatocellular de-differentiation and uncontrolled proliferation. Here, we identified SLU7, which encodes a pre-mRNA splicing regulator that is inhibited in hepatocarcinoma, as a pivotal gene for hepatocellular homeostasis. SLU7 knockdown in human liver cells and mouse liver resulted in profound changes in pre-mRNA splicing and gene expression, leading to impaired glucose and lipid metabolism, refractoriness to key metabolic hormones, and reversion to a fetal-like gene expression pattern. Additionally, loss of SLU7 also increased hepatocellular proliferation and induced a switch to a tumor-like glycolytic phenotype. Slu7 governed the splicing and/or expression of multiple genes essential for hepatocellular differentiation, including serine/arginine-rich splicing factor 3 (Srsf3) and hepatocyte nuclear factor 4α (Hnf4α), and was critical for cAMP-regulated gene transcription. Together, out data indicate that SLU7 is central regulator of hepatocyte identity and quiescence.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24865429      PMCID: PMC4071377          DOI: 10.1172/JCI74382

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  71 in total

1.  The RNA splicing factor hSlu7 is required for correct 3' splice-site choice.

Authors:  K Chua; R Reed
Journal:  Nature       Date:  1999-11-11       Impact factor: 49.962

2.  The product of the imprinted H19 gene is an oncofetal RNA.

Authors:  I Ariel; S Ayesh; E J Perlman; G Pizov; V Tanos; T Schneider; V A Erdmann; D Podeh; D Komitowski; A S Quasem; N de Groot; A Hochberg
Journal:  Mol Pathol       Date:  1997-02

Review 3.  Impairment of pre-mRNA splicing in liver disease: mechanisms and consequences.

Authors:  Carmen Berasain; Saioa Goñi; Josefa Castillo; María Ujue Latasa; Jesús Prieto; Matías A Avila
Journal:  World J Gastroenterol       Date:  2010-07-07       Impact factor: 5.742

4.  Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells.

Authors:  F Frasca; G Pandini; P Scalia; L Sciacca; R Mineo; A Costantino; I D Goldfine; A Belfiore; R Vigneri
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

5.  A noncanonical, GSK3-independent pathway controls postprandial hepatic glycogen deposition.

Authors:  Min Wan; Karla F Leavens; Roger W Hunter; Shlomit Koren; Alexander von Wilamowitz-Moellendorff; Mingjian Lu; Santhosh Satapati; Qingwei Chu; Kei Sakamoto; Shawn C Burgess; Morris J Birnbaum
Journal:  Cell Metab       Date:  2013-07-02       Impact factor: 27.287

6.  Impact of animal handling on the results of 18F-FDG PET studies in mice.

Authors:  Barbara J Fueger; Johannes Czernin; Isabel Hildebrandt; Chris Tran; Benjamin S Halpern; David Stout; Michael E Phelps; Wolfgang A Weber
Journal:  J Nucl Med       Date:  2006-06       Impact factor: 10.057

7.  CYP4F3B expression is associated with differentiation of HepaRG human hepatocytes and unaffected by fatty acid overload.

Authors:  Stéphanie Madec; Virginie Cerec; Emmanuelle Plée-Gautier; Joseph Antoun; Denise Glaise; Jean-Pierre Salaun; Christiane Guguen-Guillouzo; Anne Corlu
Journal:  Drug Metab Dispos       Date:  2011-07-21       Impact factor: 3.922

8.  The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type.

Authors:  Mariia O Yuneva; Teresa W M Fan; Thaddeus D Allen; Richard M Higashi; Dana V Ferraris; Takashi Tsukamoto; José M Matés; Francisco J Alonso; Chunmei Wang; Youngho Seo; Xin Chen; J Michael Bishop
Journal:  Cell Metab       Date:  2012-02-08       Impact factor: 27.287

9.  Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues.

Authors:  Xinmin Zhang; Duncan T Odom; Seung-Hoi Koo; Michael D Conkright; Gianluca Canettieri; Jennifer Best; Huaming Chen; Richard Jenner; Elizabeth Herbolsheimer; Elizabeth Jacobsen; Shilpa Kadam; Joseph R Ecker; Beverly Emerson; John B Hogenesch; Terry Unterman; Richard A Young; Marc Montminy
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-07       Impact factor: 11.205

10.  Gene expression in fixed tissues and outcome in hepatocellular carcinoma.

Authors:  Yujin Hoshida; Augusto Villanueva; Masahiro Kobayashi; Judit Peix; Derek Y Chiang; Amy Camargo; Supriya Gupta; Jamie Moore; Matthew J Wrobel; Jim Lerner; Michael Reich; Jennifer A Chan; Jonathan N Glickman; Kenji Ikeda; Masaji Hashimoto; Goro Watanabe; Maria G Daidone; Sasan Roayaie; Myron Schwartz; Swan Thung; Helga B Salvesen; Stacey Gabriel; Vincenzo Mazzaferro; Jordi Bruix; Scott L Friedman; Hiromitsu Kumada; Josep M Llovet; Todd R Golub
Journal:  N Engl J Med       Date:  2008-10-15       Impact factor: 91.245

View more
  27 in total

Review 1.  Splicing alterations contributing to cancer hallmarks in the liver: central role of dedifferentiation and genome instability.

Authors:  Maddalen Jimenez; María Arechederra; Matías A Ávila; Carmen Berasain
Journal:  Transl Gastroenterol Hepatol       Date:  2018-10-31

Review 2.  Alternative splicing as a regulator of development and tissue identity.

Authors:  Francisco E Baralle; Jimena Giudice
Journal:  Nat Rev Mol Cell Biol       Date:  2017-05-10       Impact factor: 94.444

Review 3.  Effect of ethanol on lipid metabolism.

Authors:  Min You; Gavin E Arteel
Journal:  J Hepatol       Date:  2019-02       Impact factor: 25.083

4.  Hepatic Knockdown of Splicing Regulator Slu7 Ameliorates Inflammation and Attenuates Liver Injury in Ethanol-Fed Mice.

Authors:  Jiayou Wang; Noah Kainrad; Hong Shen; Zhou Zhou; Paula Rote; Yanqiao Zhang; Laura E Nagy; Jiashin Wu; Min You
Journal:  Am J Pathol       Date:  2018-06-02       Impact factor: 4.307

5.  Deletion of serine/arginine-rich splicing factor 3 in hepatocytes predisposes to hepatocellular carcinoma in mice.

Authors:  Supriya Sen; Magda Langiewicz; Hassan Jumaa; Nicholas J G Webster
Journal:  Hepatology       Date:  2014-11-25       Impact factor: 17.425

6.  Degradation of splicing factor SRSF3 contributes to progressive liver disease.

Authors:  Deepak Kumar; Manasi Das; Consuelo Sauceda; Lesley G Ellies; Karina Kuo; Purva Parwal; Mehak Kaur; Lily Jih; Gautam K Bandyopadhyay; Douglas Burton; Rohit Loomba; Olivia Osborn; Nicholas Jg Webster
Journal:  J Clin Invest       Date:  2019-08-08       Impact factor: 14.808

Review 7.  Regulation of hepatocyte identity and quiescence.

Authors:  Carmen Berasain; Matías A Avila
Journal:  Cell Mol Life Sci       Date:  2015-06-19       Impact factor: 9.261

8.  Liver-Specific Deletion of SRSF2 Caused Acute Liver Failure and Early Death in Mice.

Authors:  Yuanming Cheng; Chunling Luo; Wenwu Wu; Zhiqin Xie; Xiangdong Fu; Ying Feng
Journal:  Mol Cell Biol       Date:  2016-05-16       Impact factor: 4.272

9.  Splicing regulator SLU7 preserves survival of hepatocellular carcinoma cells and other solid tumors via oncogenic miR-17-92 cluster expression.

Authors:  R Urtasun; M Elizalde; M Azkona; M U Latasa; O García-Irigoyen; I Uriarte; M G Fernández-Barrena; S Vicent; M M Alonso; J Muntané; J Prieto; M A Ávila; C Berasain
Journal:  Oncogene       Date:  2016-01-25       Impact factor: 9.867

10.  Targeting Hepatic Glutaminase 1 Ameliorates Non-alcoholic Steatohepatitis by Restoring Very-Low-Density Lipoprotein Triglyceride Assembly.

Authors:  Jorge Simon; Maitane Nuñez-García; Pablo Fernández-Tussy; Lucía Barbier-Torres; David Fernández-Ramos; Beatriz Gómez-Santos; Xabier Buqué; Fernando Lopitz-Otsoa; Naroa Goikoetxea-Usandizaga; Marina Serrano-Macia; Rubén Rodriguez-Agudo; Maider Bizkarguenaga; Imanol Zubiete-Franco; Virginia Gutiérrez-de Juan; Diana Cabrera; Cristina Alonso; Paula Iruzubieta; Manuel Romero-Gomez; Sebastiaan van Liempd; Azucena Castro; Ruben Nogueiras; Marta Varela-Rey; Juan Manuel Falcón-Pérez; Erica Villa; Javier Crespo; Shelly C Lu; Jose M Mato; Patricia Aspichueta; Teresa C Delgado; María Luz Martínez-Chantar
Journal:  Cell Metab       Date:  2020-02-21       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.